Global Vascular Access Devices Market - Analysis, Trends & Forecasts to 2021

News provided by

Dec 08, 2017, 10:00 ET

DUBLIN, Dec. 8, 2017 /PRNewswire/ --

The "Global Vascular Access Devices Market 2017-2021" report has been added to Research and Markets' offering.

The global vascular access devices market is expected to grow at a CAGR of 5.65% during the period 2017-2021.

The report, Global Vascular Access Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is rising popularity of antimicrobial-coated VADs. VADs are the prominent way of facilitating fluids, medications, and intravenous nutrition for a broad range of patients, especially for people with chronic conditions such as cancer. VADs reach little longer and deeper into the major veins that are designed for long-term secure, durable IV access.

According to the report, one driver in the market is wide application of VADs. Vascular access for an oncology patient is of paramount importance to facilitate the infusion of chemotherapy drug directly into the bloodstream. Drug administration, blood sampling, replacement of fluids, and monitoring venous pressure are the major applications of PICC. The usage of VADs plays a key role in the management of oncology patients, as they need them in all three phases (initial phases of surgery or chemotherapy, during the advanced stage, and during the last stage for palliative measures). The high demand for VADs due to their widespread application for neonates, children, and adults is the major reason for the market growth.

Further, the report states that one challenge in the market is stringent regulations coupled with product recalls. Regulatory authorities imposed a stringent regulatory labeling and framework requirement for medical devices, especially for the devices used for cancer surgeries. These devices always pose a high risk and undergo safety examination to demonstrate medical efficacy before they get the approval. The US FDA prevents unsafe devices from entering the market. Also, long clinical trials and premarket approval applications to the US FDA are required for all Class II and Class III devices (devices that are life-sustaining or life-supporting).

Key vendors

AngioDynamics
B. Braun Melsungen
Cook
C. R. Bard
Medtronic
Teleflex

Other prominent vendors

Amecath
Argon Medical Devices
Baxter
BD
Biosensors International Group
Boston Scientific
Foshan Special Medical
Guangdong Baihe Medical Technology
Others

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation By Product

Part 09: Market Segmentation By End-User

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/6q2787/global_vascular

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets